Recent discoveries highlighted a correlation between BMAL1 overexpression and a decrease in glioma invasiveness, through the inhibition of PI3K/AKT/matrix metalloproteinase-2 signaling pathway [9]. Here, BMAL1 is linked to central nervous system cancer.